This educational program titled “Assisted Reproduction Technology (ART) Academy Program”, featuring contents from Oxford University Press (OUP) and the European Society of Human Reproduction and Embryology (ESHRE), renowned for their excellence in research, patient care and education across the in vitro fertilization (IVF) specialties and considered elite among the highest-ranking scientific societies for practicing physicians. reflects a comprehensive approach, insights and guidance aiming to advance clinical practice.

The ART Academy Program is intended to provide you with updated information focused on:

• Personalization of ovarian stimulation
• Management of high responders and poor responders
• Improvement of live birth rates in potential polycystic ovary syndrome (PCOS) patients, potential mechanisms of benefit of human chorionic gonadotropin (hCG) driven luteinizing hormone (LH) activity
• Preimplantation genetic testing (PGT)/preimplantation genetic testing for aneuploidy (PGA) use for patients in ART treatment cycles
• Fresh versus frozen cycles and best selection criteria, preparation of frozen embryo transfer cycles
• Luteal phase support in frozen embryo transfer cycles

This Excerpts Edition is compiled and published by Group CCM SAL (Offshore) and consists of a collection of articles selected by Group CCM SAL (Offshore) from academic and/or research journals originally published in the English language by Oxford University Press. Group CCM SAL (Offshore) has obtained permission to publish this Excerpts Edition and to distribute it to medical professionals within United Arab Emirates, Oman, Qatar, Bahrain, Kuwait, Iraq, Jordan, Lebanon, Palestine, KSA, South Africa, Nigeria, Ghana, Kenya and Ethiopia.

Human Reproduction ©European Society of Human Reproduction and Embryology 2023

Human Reproduction Update ©European Society of Human Reproduction and Embryology 2023

Human Reproduction Open ©European Society of Human Reproduction and Embryology 2023

All rights reserved; no part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of Oxford University Press and/or Oxford Publishing Limited ("OPL"), or as expressly permitted by law.

The mention of trade names, commercial products or organizations, and the inclusion of advertisements in the Excerpts Edition does not imply a guarantee or endorsement of any kind by Oxford University Press, OPL or any of their licensors.

All reasonable precautions were taken by Oxford University Press and the original editors to verify drug names and doses, the results of experimental work and clinical findings published in the Journal. The ultimate responsibility for the use and dosage of drugs mentioned in the Journal and reproduced in this Excerpts Edition, and in interpretation of published material, lies with the medical practitioner. Oxford University Press, OPL nor any of their licensors accept any liability whatsoever in respect of any claim for damages or otherwise arising therefrom. Please inform Group CCM SAL (Offshore) of any errors.

The opinions expressed in the Journal articles reproduced in this Excerpts Edition are those of the original authors and do not necessarily reflect those of Oxford University Press, OPL or any of their licensors.

The use of registered names, trademarks, etc. in this Excerpts Edition does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore free for general use.